Updated Jul 16, 2026
Bar-Shalev Amos is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Amos Bar-Shalev is an executive associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins. He has been involved in various roles within the company, contributing to its strategic direction and operational management.
| Role | Insider |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | A — Grant or award | 7.5K | — |
Amos Bar-Shalev is an executive associated with Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins. He has been involved in various roles within the company, contributing to its strategic direction and operational management.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bar-Shalev Amos profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.